Immunohistochemical study of cellular events in lesional skin during common virus infections

Journal of Dermatology

Volumn 23, Issue 1, 1996, Pages 22-32

  Tsukahara, Tetsuya ^a   Horiuchi, Yasuhiro ^a,b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Higashi Matsuyama Med Assoc Hosp   (Japan)

Author keywords

cell surface markers; herpes simplex; Langerhans cell; measles; varicella zoster

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL SURFACE MARKER; HLA DQ ANTIGEN; HLA DR ANTIGEN; LEUKOSIALIN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; EPIDERMIS CELL; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES ZOSTER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MEASLES; MEASLES VIRUS; RASH; RUBELLA; RUBELLA VIRUS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD1; ANTIGENS, SURFACE; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CHILD; EPIDERMIS; HERPES SIMPLEX; HERPES ZOSTER; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; KERATINOCYTES; LANGERHANS CELLS; MACROPHAGE-1 ANTIGEN; MEASLES; MIDDLE AGED; RUBELLA; SKIN DISEASES, VIRAL; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 0030049305     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Highet AS, Kurts J: Virus infections, in Rook A, Wilkinson DS. Ebling FJG, Champion RH, Burton JL (eds): Textbook of Dermatology, 5th ed, Blackwell Scientific Publications, Oxford, 1992, pp 867-951.
2. Drijkoningen M, De Wolf-Peeters C, Degreef H, Desmet V: Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: An immunohistochemical study, Arch Dermatol Res, 180: 220-227, 1988.
3. Arneborne P, Biberfeld G: T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella, Infect Immun, 39: 29-35, 1983.
4. Horiuchi Y, Okuno T, Yamanishi K: Effects of varicella zoster virus and herpes simplex virus type 1 infection in vitro on the response of human peripheral blood mononuclear cells to phytohemagglutinin, Acta Med Okayama, 1995. (in press)
5. Fujioka A, Fujimura K, Sakai C, Takasu H: Improvement of atopic dermatitis following varicella zoster virus infection, Jpn J Dermatol, 103: 863, 1993. (Abstract in Japanese)
6. Graham RC Jr. Lundholm U, Kamovsky MJ: Cytochemical demonstration of peroxidase activity with 3-amino-9-ethylcarbazole, J Histochem Cytochem, 13: 150-152, 1965.
7. Harrist TJ, Muhlbauer JE, Murphy GF, et al: T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: A monoclonal antibody study, J Invest Dermatol, 80: 100-103, 1993.
8. Sprecher E, Becker Y: Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 pathogenicity, Arch Virol, 107: 191-205, 1989.
9. Ruby JC, Halliday GM, Muller HK: Differential effects of benzopyrene and dimethylbenz-anthracene on Langerhans cell distribution and contact sensitization in murine epidermis, J Invest Dermatol, 92: 150-155, 1989.
10. Miyagi T, Bhutto AM, Nonaka S: The effects of sunscreens on UVB erythema and Langerhans cell depression, J Dermatol (Tokyo), 21: 645-651, 1994.
11. Makino S, Yamaguchi F, Sata T, et al: The rash of measles is caused by a viral infection in the cells of the skin: A case report. J Dermatol (Tokyo), 21: 741-745, 1994.
12. Berman B, Duncan MR, Smith B, et al: Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells, J Invest Dermatol, 84: 54-58, 1985.
13. Reinhold U: Interferon-gamma, A potential role in the treatment of severe atopic dermatitis, Int J Dermatol, 30: 477-478, 1991.
14. Griffiths GEM, Voorhees JJ, Nickoloff BJ: Gamma interferon induces different keratinocyte cellular patterns of expression of HLA-DR and DQ and intercellular adhesion molecule-I (ICAM-I) antigens, BrJ Dermatol, 120: 1-7, 1989.
15. Iwasaka T, Sheridan JE, Aurelian L: Immunity to herpes simplex virus type 2: Recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors, Infect Immun, 42: 955-964, 1983.
16. Liew FY, Russell SM: Inhibition of pathogenic effect of effector T cells by specific suppressor T cells during influenza virus infection in mice, Nature, 304: 541-543, 1983.
17. Cunningham AL, Turner RR, Miller C, et al: Evolution of recurrent herpes simplex lesions, J Clin Invest, 75: 226-233, 1985.
18. Knowles II DM, Tolidjian B, Marboe C, et al: Monoclonal anti-human monocyte antibodies OKM1 and OKM5 possess distinctive tissue distribution including differential reactivity with vascular endothelium, J Immunol, 132: 2170-2173, 1984.
19. Ceuppens JL, Gualde N, Goodwin JS: Phenotypic heterogeneity of the OKM 1-positive lymphocyte population: Reactivity of OKM1 monoclonal antibody with a subset of the suppressor/cytotoxic T-cell population, Cell Immunol, 69: 150-165, 1982.
20. McFarland HI, Nahill SR, Maciaszek JW, Welsh RM: CD11b (Mac-1): A marker for CD8+ cytotoxic T cell activation and memory in virus infection, J Immunol, 149: 1326-1333, 1992.
21. Stingl G, Wolff-Schreiner EC, Gschnait F, Knapp W: Epidermal Langerhans cells bear Fc and C3 receptors, Nature, 268: 245-246, 1977.